[Progressive ataxia and cognitive deficits caused by premutation in the fragile-X-mental retardation gene]

G Roks1, E A Sistermans, L B A de Vries

  • 1St. Elisabeth Ziekenhuis, afd. Neurologie, Postbus 90.151, 5000 LC, Tilburg.

Insights

Fragile-X-associated tremor/ataxia syndrome (FXTAS) presents with walking difficulty, tremor, and ataxia in older men with an FMR1 gene premutation. Early recognition is crucial for patient care and family genetic counseling.

Area of Science:

  • Neurogenetics
  • Neurology

Background:

  • The FMR1 gene premutation is associated with various neurological disorders.
  • Fragile-X-associated tremor/ataxia syndrome (FXTAS) is a recently described condition affecting older male carriers.

Observation:

  • A 75-year-old man presented with progressive gait issues, intention tremor, ataxia, and cognitive decline.
  • Cerebellar MRI revealed symmetrical hyperintensities in the middle cerebellar peduncles.
  • Genetic analysis confirmed an FMR1 gene premutation with 150-200 CGG repeat expansions.

Findings:

  • The patient's progressive neurological symptoms, including parkinsonism, aligned with the FXTAS clinical phenotype.
  • MRI findings of white matter lesions and cerebellar atrophy are consistent with FXTAS.
  • The patient's condition worsened over two years, necessitating nursing home admission.

Implications:

  • Timely diagnosis of FXTAS is essential for appropriate patient management and support.
  • Identifying FXTAS in male carriers allows for genetic counseling regarding risks to offspring.
  • Female carriers of the FMR1 premutation face an elevated risk of having children with Fragile X syndrome.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.